Oppenheimer: Time To Buy Trillium Therapeutics By: Benzinga via Benzinga May 15, 2015 at 10:35 AM EDT In a report published Friday, Oppenheimer analysts initiated coverage ofTrillium Therapeutics Inc (NASDAQ: TRIL) with an Outperform ... Read More >> Related Stocks: Trillium Therapeutic